Rani Therapeutics Holdings, Inc. ( RANI) on Monday announced that its RaniPill Capsule platform technology has been accepted into the U.S. FDA's Emerging Technology Program (ETP).
SAN JOSE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced ...
FDA Finalizes Guidance on Emerging Manufacturing Tech Program The US Food and Drug Administration (FDA) on Thursday finalized its guidance detailing how drugmakers can participate in the agency's ...
The US Food and Drug Administration (FDA) accepts a wide variety of applications into its Emerging Technologies Program (ETP), and is not just focused on continuous manufacturing, said Joel Welch, ...
Biotechs are leveraging Veeva Basics to drive new ways of working, including shifting regulatory publishing strategies from outsourced to insourced. Veeva Submissions Publishing Basics provides a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results